| Financial Year |
March 31 2023 |
| Monetary Funds |
35,779,145.22 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
27,483,532.85 |
| Advances to Suppliers |
25,589,624.85 |
| Other Receivables |
3,393,380.29 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
112,904,551.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,439,826.31 |
| Total Current Assets |
208,984,672.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
682,119,388.91 |
| Investment Properties |
68,575,485.65 |
| Fixed Assetes |
2,080,043,173.81 |
| Under-construction Projects |
77,474,885.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
78,585,855.78 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,587,091.85 |
| Deferred Income Tax Assets |
2,845,368.43 |
| Other Non-Current Assets |
9,400,001.36 |
| Sub-Total of Non-Current Assets |
3,007,334,369.72 |
| Total Assets |
3,216,319,042.22 |
| Short-Term Loans |
331,005,792.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
33,363,891.98 |
| Accounts Payable |
631,470,030.20 |
| Accounts Received In Advance |
987,829.86 |
| Employee Compensation Payable |
9,528,341.91 |
| Taxes Payable |
5,393,948.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
175,982,989.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
427,603,529.01 |
| Other Current Liabilities |
321,229.35 |
| Sub-Total of Current Liabilities |
1,619,391,486.52 |
| Long-term Loans |
240,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
505,167,945.21 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,087,504.09 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
769,258,481.67 |
| Total Liabilities |
2,388,649,968.19 |
| Paid-In Capital(Or Share Stock) |
684,883,775.00 |
| Capital Surplus |
442,038,737.93 |
| Surplus Reserve |
31,502,847.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-587,650,675.38 |
| Minority Stockholder's Interest |
256,518,522.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
571,150,551.54 |
| Owner's Equity（Stockholder's Equity） |
827,669,074.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,216,319,042.22 |
